A Phase I//II Study of Computed Tomography-Guided Interstitial High-Dose-Rate Brachytherapy in Combination with Regional Positive Lymph Node Intensity-Modulated Radiation Therapy for Locally Advanced Peripheral Non-Small Cell Lung Cancer

被引：0
|
作者：
Li, X. [1 ]
Bo, W. J. [2 ]
Lin, S. [2 ]
Zhang, J. [2 ]
Wen, Q. [2 ]
Yang, B. [3 ]
Ren, P. [3 ]
Pang, H. [2 ]
机构：
[1] SouthWest Med Univ, Affilicated Hosp, Dept Oncol, Luzhou, Peoples R China
[2] SouthWest Med Univ, Affiliated Hosp, Dept Oncol, Luzhou, Sichuan, Peoples R China
[3] Southwest Med Univ, Affiliated Hosp, Luzhou, Peoples R China
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2018年 / 102卷 / 03期
关键词：
D O I：
10.1016/j.ijrobp.2018.07.1864
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TU_30_3616
引用
收藏
页码：E692 / E692
页数：1
相关论文
共 50 条
  • [31] Phase II Study of Nimotuzumab in Combination With Concurrent Chemoradiation Therapy (CRT) in Patients With Locally Advanced Non-small Cell Lung Cancer (NSCLC)
    Nishimura, Y.
    Harada, H.
    Soejima, T.
    Tsujino, K.
    Hayakawa, K.
    Kozuka, T.
    Tanaka, M.
    Sasaki, T.
    Yamamoto, N.
    Nakagawa, K.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S68 - S68
  • [32] Accelerated hypofractionated radiotherapy with concurrent full dose chemotherapy for locally advanced non-small cell lung cancer: A phase I/II study
    Glinski, Krzysztof
    Socha, Joanna
    Wasilewska-Tesluk, Ewa
    Komosinska, Katarzyna
    Kepka, Lucyna
    RADIOTHERAPY AND ONCOLOGY, 2020, 148 : 174 - 180
  • [33] A phase I study of moderate-dose radiation therapy and weekly gemcitabine in patients with locally advanced non-small cell lung cancer not suitable for radical chemoradiation therapy
    Burmeister, BH
    Fielding, DI
    Ramsay, JR
    Baumann, KC
    Dauth, M
    Walpole, ET
    CLINICAL ONCOLOGY, 2005, 17 (05) : 332 - 336
  • [34] Preliminary analysis of a phase II study of paclitaxel, carboplatin, and hyperfractionated radiation therapy for locally advanced inoperable non-small cell lung cancer
    Choy, H
    DeVore, RF
    Hande, KR
    Porter, LL
    Rosenblatt, P
    Yunus, F
    Schlabach, L
    Smith, C
    Shyr, Y
    LaPorte, K
    Johnson, DH
    SEMINARS IN ONCOLOGY, 1997, 24 (04) : 21 - 26
  • [35] Phase I study of celecoxib with concurrent irinotecan, cisplatin, and radiation therapy for patients with unresectable locally advanced non-small cell lung cancer
    Komaki, Ritsuko
    Wei, Xiong
    Allen, Pamela K.
    Liao, Zhongxing
    Miles, Luka
    Cox, James D.
    O'Reilly, Michael S.
    Chang, Joe V.
    McAleer, Mary Frances
    Jeter, Melenda
    Blumenschein, George R., Jr.
    Kies, Merrill S.
    FRONTIERS IN ONCOLOGY, 2011, 1 : 1 - 7
  • [36] Phase I/II study of docetaxel and cisplatin with concurrent thoracic radiation therapy for locally advanced non-small-cell lung cancer
    Kiura, K
    Ueoka, H
    Segawa, Y
    Tabata, M
    Kamei, H
    Takigawa, N
    Hiraki, S
    Watanabe, Y
    Bessho, A
    Eguchi, K
    Okimoto, N
    Harita, S
    Takemoto, M
    Hiraki, Y
    Harada, M
    Tanimoto, M
    BRITISH JOURNAL OF CANCER, 2003, 89 (05) : 795 - 802
  • [37] Phase I/II study of docetaxel and cisplatin with concurrent thoracic radiation therapy for locally advanced non-small-cell lung cancer
    K Kiura
    H Ueoka
    Y Segawa
    M Tabata
    H Kamei
    N Takigawa
    S Hiraki
    Y Watanabe
    A Bessho
    K Eguchi
    N Okimoto
    S Harita
    M Takemoto
    Y Hiraki
    M Harada
    M Tanimoto
    British Journal of Cancer, 2003, 89 : 795 - 802
  • [38] Combination therapy with docetaxel and low dose of cisplatin in elderly patients with advanced non-small cell lung cancer: multicenter phase II study
    Jaime Feliu
    Jose Luis Firvida
    Javier Castro
    Catherina Madroñal
    Angeles Rodríguez-Jaráiz
    Mercedes Salgado
    Cristóbal Belda-Iniesta
    Enrique Casado
    Jesús García-Mata
    Manuel González-Barón
    Cancer Chemotherapy and Pharmacology, 2009, 63 : 403 - 409
  • [39] Combination therapy with docetaxel and low dose of cisplatin in elderly patients with advanced non-small cell lung cancer: multicenter phase II study
    Feliu, Jaime
    Firvida, Jose Luis
    Castro, Javier
    Madronal, Catherina
    Rodriguez-Jaraiz, Angeles
    Salgado, Mercedes
    Belda-Iniesta, Cristobal
    Casado, Enrique
    Garcia-Mata, Jesus
    Gonzalez-Baron, Manuel
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 63 (03) : 403 - 409
  • [40] Phase I/II study of weekly docetaxel dose escalation in combination with fixed weekly cisplatin and concurrent thoracic radiotherapy in locally advanced non-small cell lung cancer
    Nobuyuki Yamamoto
    Yasumasa Nishimura
    Kazuhiko Nakagawa
    Kaoru Matsui
    Masahiro Fukuoka
    Cancer Chemotherapy and Pharmacology, 2006, 58 : 285 - 291
12345